XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 403.1 $ 542.8
Accounts receivable, less allowance for doubtful accounts 1,247.1 1,275.8
Inventories 2,344.5 2,256.5
Prepaid expenses and other current assets 396.5 352.3
Total Current Assets 4,391.2 4,427.4
Property, plant and equipment, net 2,035.8 2,015.4
Goodwill 9,593.7 9,594.4
Intangible assets, net 7,524.2 7,684.6
Other assets 660.8 405.0
Total Assets 24,205.7 24,126.8
Current Liabilities:    
Accounts payable 347.5 362.6
Income taxes payable 144.7 142.4
Other current liabilities 1,185.6 1,391.3
Current portion of long-term debt 2,000.0 525.0
Total Current Liabilities 3,677.8 2,421.3
Deferred income taxes, net 949.9 999.5
Long-term income tax payable 677.9 666.2
Other long-term liabilities 518.6 350.0
Long-term debt 6,719.3 8,413.7
Total Liabilities 12,543.5 12,850.7
Commitments and Contingencies (Note 17)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 308.8 million shares in 2019 (307.9 million in 2018) issued 3.1 3.1
Paid-in capital 8,776.5 8,686.1
Retained earnings 9,772.7 9,491.2
Accumulated other comprehensive loss (171.8) (187.4)
Treasury stock, 103.9 million shares in 2019 (103.9 million shares in 2018) (6,721.4) (6,721.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 11,659.1 11,271.3
Noncontrolling interest 3.1 4.8
Total Stockholders' Equity 11,662.2 11,276.1
Total Liabilities and Stockholders' Equity $ 24,205.7 $ 24,126.8